Ondine Biomedical Inc.
OBIMF
$0.14
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -60.02% | -52.00% | -69.18% | -71.19% | 3.54% |
| Total Depreciation and Amortization | 7.90% | 2.56% | -3.09% | -2.00% | -8.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.88% | 2.44% | 1,695.86% | 1,718.71% | -28.68% |
| Change in Net Operating Assets | 8,620.29% | 8,187.14% | 130.97% | 133.69% | 101.69% |
| Cash from Operations | -42.06% | -34.93% | -49.11% | -50.88% | 14.92% |
| Capital Expenditure | -135.14% | -127.03% | 100.00% | 100.00% | 94.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -135.14% | -127.03% | 100.00% | 100.00% | 94.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 2.68% | 2.68% | -242.59% | -242.59% | -6.16% |
| Issuance of Common Stock | -4.75% | -4.75% | 244.48% | 244.48% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.00% | 96.00% | -97.29% | -97.29% | -- |
| Cash from Financing | 3.51% | -1.69% | 300.14% | 304.89% | 2,560.00% |
| Foreign Exchange rate Adjustments | 646.67% | 610.53% | 1,201.43% | 1,216.90% | 131.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -143.79% | -131.55% | 674.24% | 681.07% | 80.02% |